Royalty Pharma AG in Liquidation

limited or corporationDeleted

Company Overview

Swiss UID, VAT number:

CHE-101.226.688

Date of incorporation:

10/12/2000

Location:

Schaffhausen

Office:

Schaffhausen

Legal Form:

limited or corporation

Capital:

CHF 226'678'087.95

Previous Company Names

Royalty Pharma AG
(Royalty Pharma SA) (Royalty Pharma Ltd)

Management

Jean-Conrad Hottinger

Zürich

Liquidator

Individual signing authority

Benjamin Schliemann

New York

Chairperson of the board

Unterschrift zu zweien

Gian Giuliani

Lugano

Member of the board

Unterschrift zu zweien

Pablo Legorreta

New York

Member of the board

Unterschrift zu zweien

David Madden

Bedford Hills

Member of the board

Unterschrift zu zweien

Stephen Evans-Freke

Tuxedo Park, NY

Member of the board

Without signing authority

Dominique Montier

London

Member of the board

Without signing authority

Donald E. Nickelson

Vero Beach

Member of the board

Without signing authority

Stanislas Poniatowski

Paris

Member of the board

Without signing authority

Rory Riggs

Ridgefield (USA)

Member of the board

Without signing authority

Carlos Rodriguez-Pastor

Lima (Peru)

Member of the board

Without signing authority

Germano Giuliani

London

Member of the board

Without signing authority

Mario Giuliani

London (GB)

Member of the board

Without signing authority

Building smart people network graph...

Fetching people and their companies

Address & Locations

Primary Address

Vordergasse 3 8200 Schaffhausen

Loading map...

SOGC Notifications

No.	Journal No.	Journal date	SOGC	SOGC date	Page / ID
1	1268	23.09.2003	186	29.09.2003	10/1191302
2	1337	08.10.2002	198	14.10.2002	9/683414
3	1094	14.08.2002	159	20.08.2002	10/607724
4	739	29.05.2002	105	04.06.2002	10/495870
5	603	26.04.2002	84	02.05.2002	12/454142
6	146	28.01.2002	22	01.02.2002	10/322614
7	929	20.07.2001	143	26.07.2001	5765
8	353	19.03.2001	58	23.03.2001	2174
9	29	08.01.2001	8	12.01.2001	270
10	1240	12.10.2000	203	18.10.2000	7121

Company Purpose

Beteiligung an Unternehmen, insbesondere mit Tätigkeitsbereichen auf dem Gebiet der Pharmaindustrie und der Biotechnologie; kann Liegenschaften und Immaterialgüterrechte erwerben, belasten, verwerten und verkaufen.